Targeting Tumor Vasculature With an Oncolytic Virus
Open Access
- 1 May 2011
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 19 (5), 886-894
- https://doi.org/10.1038/mt.2011.26
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteasesNature Medicine, 2010
- Double trouble for tumours: Exploiting the tumour microenvironment to enhance anticancer effect of oncolytic virusesCytokine & Growth Factor Reviews, 2010
- Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in miceJCI Insight, 2010
- Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancerNature Reviews Cancer, 2009
- The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular CarcinomaMolecular Therapy, 2008
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shieldedNature Reviews Microbiology, 2008
- Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endotheliumBlood, 2004
- Getting oncolytic virus therapies off the groundCancer Cell, 2003
- The Role of CC Chemokine Receptor 2 in Alveolar Monocyte and Neutrophil Immigration in Intact MiceAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Viral Vascular Endothelial Growth Factor Plays a Critical Role in Orf Virus InfectionJournal of Virology, 2000